Cancer Care Ontario | Cancer Care Ontario

First-line treatment of adult patients diagnosed with FLT3-mutated acute myeloid leukemia, in combination with specific standard induction followed by consolidation chemotherapy, according to clinical criteria

Show More Show more tags

, Show Less Show fewer tags

Drugs Used:

cytarabine,

midostaurin

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Oct 2018

Guidelines and Advice

Guidance for Kyphoplasty and Vertebroplasty for Cancer Patients in Ontario: Recommendations Report 2017

Status: Current
Version: 2

Oct 2018

Cancer facts

Over 1,300 annual cancer cases caused by HPV could be prevented in Ontario

Oct 2018

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2018

Status: Current
ID: pet 2018-1
Version: n/a

Oct 2018

Guidelines and Advice

Cancer Screening for Persons at Risk for or Affected with Lynch Syndrome Evidence Summary

Status: In-Review
ID: ES 15-16

Oct 2018

PET Imaging in Pancreatic Cancer

PET Imaging in Melanoma

Interventions to Increase the Uptake of Cancer Screening

High-Intensity Focused Ultrasound for Prostate Cancer

Gastroscopy Following a Positive Fecal Occult Blood Test (FOBT) and Negative Colonoscopy

Adult Sarcoma Management in Ontario

Managing System Pressures for Sarcoma Service Delivery in Ontario

CYTA(HD)+MIDO

Guidance for Kyphoplasty and Vertebroplasty for Cancer Patients in Ontario: Recommendations Report 2017

Over 1,300 annual cancer cases caused by HPV could be prevented in Ontario

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2018

Cancer Screening for Persons at Risk for or Affected with Lynch Syndrome Evidence Summary

Pages